Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Melanocortin Type 1 Receptor (MC1R) is a G protein-coupled receptor primarily expressed on melanocytes, playing a key role in regulating skin and hair pigmentation. Upon activation by agonists like α-MSH, MC1R stimulates eumelanin production, providing photoprotection. Loss-of-function variants are associated with fair skin, red hair, and increased melanoma risk. Beyond pigmentation, MC1R is also involved in immune modulation and DNA repair. The agouti signaling protein acts as an antagonist. Drugs like afamelanotide are used therapeutically.
Agonist binding activates adenylyl cyclase, increasing cAMP levels and promoting eumelanin synthesis and DNA repair. Antagonists inhibit this pathway, favoring pheomelanin synthesis.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Melanocortin Type 1 Receptor (MC1R).